{
  "id": 784405,
  "title": "PTC takes a chance on Sangamo’s Fabry disease gene therapy",
  "url": "https://urgent.news/2026/08/13/ptc-takes-a-chance-on-sangamos-fabry-disease-gene-therapy",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-13T15:10:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/ptc-sangamo-fabry-gene-therapy-bankruptcy-sale-lilly/827767/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Wall Street analysts view the deal as a risky, high-reward bet on a treatment that’s nearing a possible regulatory approval and could be superior to existing medications.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}